Treace Medical Concepts Files 8-K on Officer/Director Changes
Ticker: TMCI · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1630627
| Field | Detail |
|---|---|
| Company | Treace Medical Concepts, Inc. (TMCI) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, compensation
Related Tickers: TMCI
TL;DR
Treace Medical Concepts (TMCI) filed an 8-K detailing leadership changes and compensation - watch for updates.
AI Summary
Treace Medical Concepts, Inc. filed an 8-K on April 7, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and executive compensation structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or performance.
Key Players & Entities
- TREACE MEDICAL CONCEPTS, INC. (company) — Registrant
- April 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40355 (filing_number) — SEC File Number
- 47-1052611 (ein) — IRS Employer Identification Number
- 100 Palmetto Park Place (address) — Principal executive offices
- Ponte Vedra (city) — Principal executive offices
- Florida (state) — Principal executive offices
- 32081 (zip_code) — Principal executive offices
- ( 904 ) 373-5940 (phone_number) — Registrant's telephone number
FAQ
What specific roles have seen departures or appointments?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' but does not specify the exact roles in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported was on April 7, 2025.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the SEC file number for Treace Medical Concepts, Inc.?
The SEC file number is 001-40355.
What is the primary business address of the registrant?
The primary business address is 100 Palmetto Park Place, Ponte Vedra, Florida 32081.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding TREACE MEDICAL CONCEPTS, INC. (TMCI).